FWP
BSX icon

Forefront Wealth Partners’s Boston Scientific BSX Stock Holding History

Forefront Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408K Buy
6,499
+4,274
+192% +$342K 0.17% 109
2025
Q4 		$212K Buy
2,225
+118
+6% +$11.6K 0.1% 133
2025
Q3 		$206K Buy
+2,107
New +$218K 0.05% 183

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Forefront Wealth Partners's BSX Position: Q1 2026 in Review

Forefront Wealth Partners increased its Boston Scientific (BSX) stake by 192% in Q1 2026, buying an estimated $342K and bringing the position to 6,499 shares worth $408K. The position accounts for 0.17% of the portfolio, ranked #109.

Forefront Wealth Partners first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Forefront Wealth Partners held 6,499 shares of Boston Scientific worth $408K as of Q1 2026.
  • Forefront Wealth Partners bought 4,274 Boston Scientific shares in Q1 2026, an estimated $342K.
  • Boston Scientific made up 0.17% of Forefront Wealth Partners's portfolio in Q1 2026, its #109 holding.
  • Forefront Wealth Partners first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Forefront Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.